Hemagen Diagnostics Profile

0.01
USD 0.00  0.00%
33%
0%

Acquisition by William Hales of 406208 shares of Hemagen Diagnostics subject to Rule 16b-3

Hemagen Diagnostics insider trading alert for grant of stock options by William Hales, President, on June 19, 2018. This event was filed by Hemagen Diagnostics Inc with SEC on 2009-03-18. Statement of changes in beneficial ownership - SEC Form 4. William Hales is currently serves as executive chairman, ceo and president chairman of nominating committee, member of audit committee and member of compensation committee of Hemagen Diagnostics [view details]   

Hemagen Diagnostics Summary

Hemagen Diagnostics (HMGN) is traded on OTC Market in USA. It is located in 9033 Red Branch Road and employs 15 people. The company currently falls under 'Nano-Cap' category with current market capitalization of 155 K. Hemagen Diagnostics has 15.5 M outstanding shares of which 0 shares are currently shorted by private and institutional investors with about 0.11 trading days to cover. HEMAGEN DIAG INC currently holds about 66.29 K in cash with (358.69 K) of positive cash flow from operations.
Check Hemagen Diagnostics Probability Of Bankruptcy

Hemagen Diagnostics Risk Profiles

Key Fundamentals

Hemagen Diagnostics Against Markets

Current Ratings

Hemagen Diagnostics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
11 
Chance of
Financial Distress (0 to 100%)
80 
Equity ratings for Hemagen Diagnostics are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in USA and traded on OTC Market. It employs 15 people. more
NameHemagen Diagnostics
ChairmanWilliam HalesView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address9033 Red Branch Road
ExchangeOTC Market
SectorHealthcare
BenchmarkDOW
Websitewww.hemagen.com
Phone443 367 5500
CurrencyUSD - US Dollar

Executives

Hemagen Diagnostics Corporate Executives
Please also check Risk vs Return Analysis. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.